Riskpilot← Back to searchSign inGet full accessCarl Sars AB
ABActiveOrg 5592645062Wittstocksgatan 10General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2025
SEK 741K
+7% vs 2024
EBITDA margin
73.2%
-10% vs 2024
Equity ratio
77.5%
Financial strength
Net profit 2025
SEK 426K
-10% vs 2024
| Revenue | SEK 741K | +7% |
| EBITDA | SEK 542K | -10% |
| Net profit | SEK 426K | -10% |
| Total assets | SEK 1,4M | +36% |
| Equity | SEK 1M | +39% |
| Employees | 0 | — |
Legal name
Carl Sars AB
Org number
5592645062
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 juli 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultverksamhet där bolaget hyr ut personal till hälso- och sjukvården samt bedriver rådgivning, undervisning och utveckling inom medicin samt därmed förenlig verksamhet. Aktiebolaget ska bedriva rådgivning inom vetenskapligt skrivande och medicinsk journalistik, samt konsulttjänster inom medicinsk rådgivning till läkemedelsindustri. Bolaget investerar även i värdepapper, fastigheter och fastighetsförvaltning och därmed förenlig verksamhet
Address
Wittstocksgatan 10
Email
carlsars@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 240 | 71 | 261 | 695 | 741 |
| Staff expenses | — | — | — | −17 | 82 |
| EBITDA | 208 | 28 | 194 | 600 | 542 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 208 | 28 | 194 | 600 | 542 |
| Net financials | — | — | −1 | −1 | −2 |
| Profit before tax | 207 | 28 | 193 | 599 | 540 |
| Tax | −44 | −6 | −41 | −126 | −114 |
| Net profit | 163 | 22 | 152 | 473 | 426 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 306 | 279 | 371 | 999 | 1 355 |
| Equity | 188 | 210 | 280 | 753 | 1 050 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 118 | 69 | 92 | 246 | 305 |
| Total debt | 118 | 69 | 92 | 246 | 305 |
EBITDA margin
73.2%
This company
15.8%
Market median
+363% vs market
20212025
Equity ratio
77.5%
This company
38.2%
Market median
+103% vs market
20212025
Return on equity
40.6%
This company
18.4%
Market median
+121% vs market
20212025
Net profit margin
57.5%
This company
8.1%
Market median
+610% vs market
20212025
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Carl Sars AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl David Sars | Board of Directors | 0 companies |
| Carl Erik Sars | Deputy Board Member | 0 companies |